Chinese prostate cancer screening:current situation and challenges

Gang ZHU,Kai ZHANG

DOI: https://doi.org/10.6040/j.issn.1671-7554.0.2018.1053

2019-01-01

Abstract:The incidence of prostate cancer in China has been increasing rapidly in recent years. Randomized studies in Europe have showed that PSA-based screening can reduce mortality, but it may lead to overdiagnosis and subsequent overtreatment. Large-scale randomized controlled prostate cancer screening has not yet been conducted in China. Emerging techniques and strategies may improve prostate cancer screening; however, they will surely meet challenges which require newsolutions.